Eva Winter1, Tor Elsås, Dordi Austeng. Show Affiliations » 1. Department of Ophthalmology, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Abstract
Entities: Disease Gene
Mesh: See more » AdultAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useArteriovenous Malformations/complicationsArteriovenous Malformations/diagnosisBevacizumabFemaleFluorescein AngiographyHumansMacular Edema/diagnosisMacular Edema/drug therapyMacular Edema/etiologyRetinal Artery/abnormalitiesRetinal Artery/pathologyRetinal Vein/abnormalitiesRetinal Vein/pathologyTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual Acuity
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2012 PMID: 23241246 DOI: 10.1111/aos.12019
Source DB: PubMed Journal: Acta Ophthalmol ISSN: 1755-375X Impact factor: 3.761